Patient Guide: Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 15 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT03040973
Status: ACTIVE_NOT_RECRUITING
Condition: Advanced Solid Tumors Which Are cMET-dependent
Phase: PHASE2

Find a Study Location Near You

This study is available at 15 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Boston, Massachusetts
  • Leuven,
  • Edmonton, Alberta
  • • And 12 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily